focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,789.50
Bid: 1,789.00
Ask: 1,790.00
Change: -23.00 (-1.27%)
Spread: 1.00 (0.056%)
Open: 1,792.50
High: 1,802.00
Low: 1,789.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: GSK settles Zantac litigation in California

Fri, 23rd Jun 2023 07:58

(Alliance News) - Stocks in London are set to open in the red on Friday, as risk sentiment across the globe is damped by hawkish central banks.

On Thursday, the Bank of England surprised with a chunkier-than-expected 50 basis point interest rate hike.

A 25 basis point hike had been largely expected. However, following Wednesday's red-hot consumer price index data, bets on a half-point hike had increased, with the expectation that a more aggressive move may better tame the UK's stubborn annual inflation rate.

Defying the otherwise gloomy mood, government data showed UK retail sales volumes held up better than expected in May, boosted by sunny weather. In addition, GfK's UK consumer confidence indicator ticked up, despite the cost-of-living crisis and double-digit grocery inflation.

In early UK company news, GSK said it has reached a confidential settlement in a lawsuit related to Zantac in California. HSBC downgraded stocks of blue-chip housebuilders, meanwhile.

Revolution Beauty boasted a 60% year-on-year increase in sales at the beginning of its financial year and continued to hit out at boohoo.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 18.8 points, 0.3%, at 7,483.23

----------

Hang Seng: down 1.9% at 18,850.50

Nikkei 225: closed down 1.5% at 32,781.54

S&P/ASX 200: closed down 1.3% at 7,099.20

----------

DJIA: closed down just 4.81 points at 33,946.71

S&P 500: closed up 16.20 points, or 0.4%, at 4,381.89

Nasdaq Composite: closed up 128.41 points, or 1.0%, at 13,630.61

----------

EUR: down at USD1.0932 (USD1.0953)

GBP: down at USD1.2706 (USD1.2741)

USD: up at JPY143.39 (JPY142.86)

Gold: up at USD1,915.28 per ounce (USD1,913.60)

Oil (Brent): down at USD73.47 a barrel (USD74.22)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

10:00 CEST EU flash PMI

09:15 CEST France flash PMI

09:30 CEST Germany flash PMI

09:00 CEST Spain GDP

09:00 CEST Switzerland balance of payments

09:30 BST UK flash PMI

12:00 BST UK BoE market participants survey results

07:30 EDT US Fed Atlanta President Raphael Bostic speaks

09:45 EDT US flash manufacturing PMI

09:45 EDT US flash services PMI

----------

Consumer confidence in the UK has climbed in June, despite red-hot inflation, amid growing optimism on personal finances. GfK's consumer confidence index increased three points to negative 24 in June, from a tally of negative 27 in May. It marks the fifth monthly improvement in-a-row. Despite "fierce economic headwinds", three measures were up, while one was down and one was unchanged. The index measuring changes in personal finances during the last 12 months was up five points on-month at minus 15, eight points better off a year prior. The general economic situation index during the last 12 months was unchanged monthly at minus 54. It was 11 points higher than in June 2022, however. The major purchase index, an indicator of confidence in buying big ticket items, was down one point to minus 25 in June, from minus 24 in May, however. It was =16 points higher than the same time last year.

----------

UK retail sales volumes held up better than expected in May, according to government data, boosted by sunny weather. The Office for National Statistics said retail sales fell 2.1% annually in May, easing from a downwardly revised fall of 3.4% in April. The market had been expecting a 2.6% fall for May, according to FXStreet-cited consensus. April's reading was previously reported as a 3.0% decline. From the previous month, sales ticked up 0.3% in May, slowing from a 0.5% rise in April. However, the reading was better than market consensus, which had forecast a 0.2% decline.

----------

BROKER RATING CHANGES

----------

JPMorgan places BHP and Rio Tinto on 'negative catalyst watch'

----------

HSBC cuts Berkeley Group to 'reduce' - price target 3,000 pence

----------

HSBC cuts Persimmon to 'hold' - price target 1,190 pence

----------

COMPANIES - FTSE 100

----------

GSK said it has reached a confidential settlement with James Goetz, a claimant in Zantac litigation. The case he filed in California state court, which was set to begin in July, will now be dismissed. "The settlement reflects the company's desire to avoid distraction related to protracted litigation in this case. GSK does not admit any liability in this settlement and will continue to vigorously defend itself based on the facts and the science in all other Zantac cases," the pharmaceutical company said.

----------

Shell and BP were among the fossil fuel companies named in a US lawsuit. A county in the northwestern state of Oregon on Thursday filed suit against major fossil fuel corporations seeking more than USD51 billion over the 2021 "Heat Dome", one of the US' deadliest ever weather disasters. Multnomah County, which encompasses the state's most populous city Portland, said combined historic carbon pollution from use of the companies' products – and their decision to mislead the public about their impacts – was a big factor in exacerbating the heat wave. Multnomah County's suit names major oil firms including ExxonMobil, Shell, Chevron and BP, but also the American Petroleum Institute and Western States Petroleum Association, trade groups, as well as consultancy McKinsey & Company.

----------

The UK Competition & Markets Authority said it was beginning a merger investigation into Severn Trent's buy of Andigestion. On Monday, the CMA had said it was considering whether the merger would create any lessening of competition in any UK markets, and invited interested parties to comment. Water utility Severn Trent had announced its green power unit's acquisition of Andigestion in February. Andigestion which operates two food waste anaerobic digestion plants in southwest England. It disclosed no financial details. The CMA said it has a deadline of August 18 for its phase 1 decision.

----------

OTHER COMPANIES

----------

Revolution Beauty hailed its recent trading, and took aim at boohoo for its recent "hostile" attempts to re-shape the embattled beauty company's board. Revolution Beauty said trading has been "excellent" in the first three months of the financial year ending February 28, with sales up 60% year-on-year, and gross margins improving to 48.2% from 41.7%. In recent days, online fast fashion retailer boohoo, which holds just under a 27% stake in Revolution, has attempted to replace the company's board. "boohoo's stated rationale for the proposed changes to the Revolution Beauty board is that the focus of the group must switch to growth. The company hopes that shareholders are reassured that the current board is similarly minded and that growth is being delivered without one shareholder taking control of the board at the expense of the interests of other shareholders," Revolution Beauty said. Among boohoo's latest proposed additions was Rachel Horsefield, former chief executive of THG Beauty, a company Revolution Beauty "has recently undertaken to cease commercial relationships" with. "The board of Revolution Beauty believes that boohoo's announcement yesterday vindicates its view," Revolution Beauty explained, affirming that members of its own board are better-placed to drive than company forward than those boohoo recommends.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.